2023 Drug Development Health Technology 
Digital Health Global
JANUARY 4, 2024
Koneksa’s innovative digital model aims to address limitations in existing functional status assessments by leveraging digital health technologies (DHTs) for both objective and self-reported outcomes. Chief Medical Officer, Koneksa. Chief Scientific Officer, Koneksa.
Digital Health Global
NOVEMBER 20, 2023
We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” What future for health spending? Accessed November 2023.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
APRIL 5, 2024
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. growth between 2023 to 2024. Overall R&D expenditure totals about $276.81 billion, with a slow 2.5%
Digital Health Global
DECEMBER 5, 2023
Alzheimer’s disease will affect 13 million Americans by 2050 , up from 6 million in 2023. Also, the financial burden in the United States is tremendous, expected to exceed $345 billion in 2023 and surpass $1 trillion by 2050.
Digital Health Global
JANUARY 9, 2024
The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “ Our mutual dedication to building new approaches to pharmaceutical drug development and patient care will help bring promising pre-approval medicine to patients around the world, faster and more equitably. .
Expert insights. Personalized for you.
88 
Let's personalize your content